|
Volumn 56, Issue SUPPL. 1, 2008, Pages 110-120
|
Efficacy and safety of sitafloxacin in patients with otorhinolaryngological infections and its tissue distribution in the otorhinolaryngological field
a b c d e f |
Author keywords
Clinical trial; Otorhinolaryngological infections; Pharmacokinetics; Sitafloxacin
|
Indexed keywords
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SITAFLOXACIN;
ACUTE OTITIS MEDIA;
ADULT;
ARTICLE;
CHRONIC OTITIS MEDIA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE EXACERBATION;
DRUG BLOOD LEVEL;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG PENETRATION;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG TISSUE LEVEL;
EAR NOSE THROAT DISEASE;
ERADICATION THERAPY;
ETHMOID SINUS;
FEMALE;
HUMAN;
LARYNGITIS;
MAJOR CLINICAL STUDY;
MALE;
MAXILLARY SINUS;
MIDDLE EAR MUCOSA;
NONHUMAN;
PALATINE TONSIL;
PARANASAL SINUSITIS;
PHARYNGITIS;
RHINOSINUSITIS;
SINGLE DRUG DOSE;
TISSUE DISTRIBUTION;
TONSILLITIS;
UNSPECIFIED SIDE EFFECT;
|
EID: 43449087342
PISSN: 13407007
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (16)
|